Search

Displaying results 6901 - 6910 of 6949 in total
  1. Drug

    Fluasterone

    go.drugbank.com/drugs/DB06250
    Experimental

    Has antiproliferative effects on HIV-1 and reduces HIV-1 replication.

  2. Drug

    Latiglutenase

    go.drugbank.com/drugs/DB06326
    Investigational

  3. Drug

    RDEA806

    go.drugbank.com/drugs/DB05228
    Investigational

    RDEA806 is a new HIV non-nucleoside reverse transcriptase inhibitor (NNRTI) with a high genetic barrier to resistance and a broad spectrum of activity.

  4. Drug

    Tifuvirtide

    go.drugbank.com/drugs/DB05413
    Investigational

    Tifuvirtide is the first members of a new class of anti-HIV drugs which is also called fusion inhibitors. It has received fast-track designation from the FDA and is in Phase I/II clinical testing.

  5. Drug

    P54

    go.drugbank.com/drugs/DB05451
    Experimental

    P54 reduces the inflammation associated with cancer/tumors, Crohn's disease, inflammatory bowel disease, osteoarthritis, and ulcerative colitis. It inhibits the induction of the enzyme NFkB, thereby inhibiting downstream inflammatory gen...

  6. Drug

    Enrasentan

    go.drugbank.com/drugs/DB06460
    Experimental

    Categories: Endothelin Receptor Antagonists
  7. Drug

    Amdoxovir

    go.drugbank.com/drugs/DB06619
    Investigational

  8. Drug

    Capravirine

    go.drugbank.com/drugs/DB08502
    Investigational

  9. Drug

    alpha-Pyrrolidinononanophenone

    go.drugbank.com/drugs/DB05531
    Investigational

  10. Drug

    LM-609

    go.drugbank.com/drugs/DB05787
    Experimental

    LM-609 (Vitaxin) is an artificial antibody that targets a protein on the surface of newly forming blood vessels, as well as on certain tumors. In addition to cancer, the protein has been implicated in bone destruction in rheumatoid arthr...